HIV Tat & cocaine-mediated alterations in microglial migration & activation involve epigenetic reulation of miRNAs
HIV Tat & cocaine-mediated alterations in microglial migration & activation involve epigenetic reulation of miRNAs
批准号:
9236010
负责人:
Shilpa J. Buch
金额:
$37.63万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-05-31
关键词:
AIDS/HIV problemAddressAnti-Inflammatory AgentsAnti-Retroviral AgentsAnti-inflammatoryBiological AssayBloodBrainCell LineCell physiologyCellsChemotactic FactorsClinicalCocaineCocaine AbuseCognitiveCorpus striatum structureDNADNA MethylationDNA SequenceDataDevelopmentDown-RegulationDrug abuseEnd Point AssayEpigenetic ProcessExhibitsFutureGene ExpressionGenetic TranscriptionGenomic DNAGlobal ChangeGoalsHIVHIV Envelope Protein gp120HIV InfectionsHIV SeropositivityHIV Transactivator ProteinHIV-1HIV-associated neurocognitive disorderImmunoprecipitationImpairmentIn VitroIndividualInflammatoryLeadLifeLinkLongevityLuciferasesMacaca mulattaMediatingMethylationMicroRNAsMicrogliaMinorMolecularMolecular ProfilingMonocyte Chemoattractant ProteinsMusNeuraxisNeurogliaNeuronsPathogenesisPathologyPatientsPeptidesPharmaceutical PreparationsPhenotypePlayPrevalenceProcessProteinsRNARecording of previous eventsRegulationRoleSIVSignal TransductionSubstance abuse problemTLR4 geneTestingTherapeutic InterventionTissuesTrans-ActivatorsUntranslated RNAUp-RegulationViral Load resultViral ProteinsVirus DiseasesVirus ReplicationWestern BlottingWound Healingabstractingbasebisulfitechromatin immunoprecipitationcombinatorialcytokinedrug of abuseepigenomicsexperiencegenetic approachglial activationglobal healthin vivomacrophagemigrationmotor disordernervous system disorderneuroinflammationnew therapeutic targetnovelpromotersymptomatologyvirus envelope
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract:
Drug abuse and HIV-1 are two linked global health crises. Despite the recognized impact of cocaine abuse on
the clinical course of HIV-1-associated neurological disorder (HAND), the mechanisms underlying the ability of
cocaine to modulate central nervous system (CNS) pathology remain elusive. Neuroinflammation involving
robust microglial activation has emerged as an important phenotype and correlate of HIV infection and drug
abuse despite the advent of combined anti-retroviral therapy (cART). The underlying cause of HIV-associated
neuroinflammation is likely attributable to the fact that following virus infection and formation of the proviral
DNA, cART is ineffective in abrogating the expression of toxic viral gene products such as Tat and gp120, that
continue to be present in tissues such as the CNS. Furthermore, similar to HIV positive subjects on cART, SIV-
infected rhesus macaques on cART also demonstrate increased glial activation, which was shown to be
associated with dysregulation of various signature microRNAs (miRs). Emerging evidence also points to the
role of drugs such as cocaine in mediating glial activation with global changes in miRs. In fact, in a recent
finding, we demonstrate that cocaine-mediated activation of microglia involves down-regulation of miR-124
expression both in vitro and in vivo. Furthermore, we have also elucidated that HIV Tat mediated microglial
migration involves upregulated expression of miR-9 with a concomitant downregulation of its target, monocyte
chemotactic protein-induced protein 1 (MCPIP1). We thus hypothesize that both cocaine and HIV Tat modulate
increased microglial activation and migration respectively, via two distinct mechanisms: a) cocaine mediates
downregulation of miR-124 via DNA methylation of its promoter, leading in turn, to increased TLR4 signaling
that culminates into increased microglial activation and, b) exposure of microglia to HIV Tat upregulates the
expression of miR-9 leading in turn, to enhanced microglial migration via downregulation of the target MCPIP1.
Three experienced PIs (Drs. Buch, Hu, & Guo) will co-lead this project to accomplish the proposed goals. This
proposal is responsive to the RFA (RFA-DA-16-012) focusing on epigenomic and non-coding RNA regulation
in HIV/AIDS and substance abuse.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Single cell determinants of brain in the context of viral persistence in SIV/cART/cocaine non-human primates
-
批准号:10683001
-
项目类别:
-
资助金额:$249.41万
-
财政年份:2023
-
负责人:Shilpa J. Buch
-
依托单位:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
-
批准号:10686187
-
项目类别:
-
资助金额:$36.53万
-
财政年份:2022
-
负责人:Shilpa J. Buch
-
依托单位:
Title: Pharmacokinetic, pharmacodynamic , and toxicological interactions among Opioids and Cabotegravir
-
批准号:10548530
-
项目类别:
-
资助金额:$37.4万
-
财政年份:2022
-
负责人:Shilpa J. Buch
-
依托单位:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
-
批准号:10665734
-
项目类别:
-
资助金额:$209.91万
-
财政年份:2021
-
负责人:Shilpa J. Buch
-
依托单位:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
-
批准号:10656918
-
项目类别:
-
资助金额:$12.58万
-
财政年份:2021
-
负责人:Shilpa J. Buch
-
依托单位:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
-
批准号:10220475
-
项目类别:
-
资助金额:$141.74万
-
财政年份:2021
-
负责人:Shilpa J. Buch
-
依托单位:
Uncovering HIV/opioid effects in the brain at the single cell level: transcription, chromatin accessibility, and reservoir analysis in the SIV/cART/morphine/rhesus monkey model
-
批准号:10469423
-
项目类别:
-
资助金额:$209.33万
-
财政年份:2021
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10161058
-
项目类别:
-
资助金额:$10.78万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10450546
-
项目类别:
-
资助金额:$1.52万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10846423
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10665604
-
项目类别:
-
资助金额:$51.47万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10019506
-
项目类别:
-
资助金额:$37.74万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10453612
-
项目类别:
-
资助金额:$51.47万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Molecular mechanisms underlying HIV & Cocaine-mediated microglial activation: Targeting NLRP3 inflammasome
-
批准号:10237304
-
项目类别:
-
资助金额:$47.63万
-
财政年份:2019
-
负责人:Shilpa J. Buch
-
依托单位:
Mechanisms underlying dysregulated neuroimmune signaling and neuronal dysfunction in HIV (+) individuals with cART and cocaine
-
批准号:10458061
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2018
-
负责人:Shilpa J. Buch
-
依托单位:
Mechanisms underlying dysregulated neuroimmune signaling and neuronal dysfunction in HIV (+) individuals with cART and cocaine
-
批准号:10241327
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2018
-
负责人:Shilpa J. Buch
-
依托单位:
Mechanisms underlying dysregulated neuroimmune signaling and neuronal dysfunction in HIV (+) individuals with cART and cocaine
-
批准号:9978793
-
项目类别:
-
资助金额:$36.22万
-
财政年份:2018
-
负责人:Shilpa J. Buch
-
依托单位:
The brain as a SIV reservoir under suppressive cART potentiation by drugs of abuse
-
批准号:9236779
-
项目类别:
-
资助金额:$75.22万
-
财政年份:2016
-
负责人:Shilpa J. Buch
-
依托单位:
The combinatorial effects of Opiates and the emerging promoter-variant strains of HIV-1 subtype C on HIV neuropathogensis and latency
-
批准号:9982822
-
项目类别:
-
资助金额:$71.88万
-
财政年份:2016
-
负责人:Shilpa J. Buch
-
依托单位:
The brain as a SIV reservoir under suppressive cART potentiation by drugs of abuse
-
批准号:9757733
-
项目类别:
-
资助金额:$75.22万
-
财政年份:2016
-
负责人:Shilpa J. Buch
-
依托单位:
海外基金